The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling
- PMID: 20036661
- DOI: 10.1016/j.febslet.2009.12.039
The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling
Abstract
Plasma membrane urokinase-type plasminogen activator (uPA)-receptor (uPAR) is a GPI-anchored protein that binds with high-affinity and activates the serine protease uPA, thus regulating proteolytic activity at the cell surface. In addition, uPAR is a signaling receptor that often does not require its protease ligand or its proteolytic function. uPAR is highly expressed during tissue reorganization, inflammation, and in virtually all human cancers. Since its discovery, in vitro and in vivo models, as well as retrospective clinical studies have shown that over-expression of components of the uPA/uPAR-system correlates with increased proliferation, migration, and invasion affecting the malignant phenotype of cancer. uPAR regulates the cells-extracellular matrix interactions promoting its degradation and turnover through the plasminogen activation cascade.
Copyright 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface.Biol Chem Hoppe Seyler. 1995 May;376(5):269-79. Biol Chem Hoppe Seyler. 1995. PMID: 7662169 Review.
-
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398. Stem Cells. 1997. PMID: 9402652 Review.
-
The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.Biol Chem. 2004 Feb;385(2):103-36. doi: 10.1515/BC.2004.031. Biol Chem. 2004. PMID: 15101555 Review.
-
Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.J Proteome Res. 2008 Nov;7(11):4792-806. doi: 10.1021/pr800357h. Epub 2008 Sep 23. J Proteome Res. 2008. PMID: 18808175
-
Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.J Immunol Methods. 2008 Nov 30;339(1):55-65. doi: 10.1016/j.jim.2008.08.002. Epub 2008 Aug 30. J Immunol Methods. 2008. PMID: 18761343
Cited by
-
Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.Mol Cancer Res. 2012 Dec;10(12):1532-43. doi: 10.1158/1541-7786.MCR-12-0349. Epub 2012 Oct 4. Mol Cancer Res. 2012. PMID: 23038812 Free PMC article.
-
Enhanced Expression of Plasminogen Activators and Inhibitor in the Healing of Tympanic Membrane Perforation in Rats.J Assoc Res Otolaryngol. 2023 Apr;24(2):159-170. doi: 10.1007/s10162-023-00891-5. Epub 2023 Feb 21. J Assoc Res Otolaryngol. 2023. PMID: 36810718 Free PMC article.
-
The NuRD chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis.PLoS Genet. 2013;9(12):e1004031. doi: 10.1371/journal.pgen.1004031. Epub 2013 Dec 12. PLoS Genet. 2013. PMID: 24348274 Free PMC article.
-
Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases.Chronic Dis Transl Med. 2017 Nov 26;3(4):207-212. doi: 10.1016/j.cdtm.2017.09.002. eCollection 2017 Dec. Chronic Dis Transl Med. 2017. PMID: 29354803 Free PMC article.
-
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.J Hematol Oncol. 2017 Jan 13;10(1):16. doi: 10.1186/s13045-016-0385-8. J Hematol Oncol. 2017. PMID: 28086938 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous